NCT06786780View on ClinicalTrials.gov

Establishment and Validation of Prediction Model of Simultaneous Chemoradiotherapy for Cervical Cancer Organoids

PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2026

Conditions
Cervical Cancer Treated with Pelvic RadiotherapyCervical Cancers
Interventions
COMBINATION_PRODUCT

Drug: Cisplatin

Organoids were constructed prior to simultaneous radiochemical therapy

Trial Locations (1)

400000

Chongqing university Cancer Hospital, Chongqing

All Listed Sponsors
lead

Chongqing University Cancer Hospital

OTHER